Cancer and Blood Institute of the Desert
Rancho Mirage, California, United States
Cancer treatment center in Rancho Mirage, California
39700 Bob Hope Dr Suite 108, Rancho Mirage, CA 92270
About Cancer and Blood Institute of the Desert
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pharmatech Oncology
2
Sanofi
2
Clinical Trials at Cancer and Blood Institute of the Desert
During the past decade, Cancer and Blood Institute of the Desert conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
1998-12-01
Terminated
425
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
1998-08-01
2001-01-01
Completed
600
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
1999-11-01
2004-09-01
Completed
127
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1999-12-01
Unknown status
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
2000-10-01
Unknown status
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
2000-12-01
2008-10-01
Completed
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2001-07-01
2005-04-01
Completed
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
2000-12-01
2003-06-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer and Blood Institute of the Desert" #1 sponsor was "Pharmatech Oncology" with 2 trials, followed by "Sanofi" with 2 trials
sponsored, "AVAX Technologies" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Daiichi Sankyo, Inc."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Blood Institute of the Desert"
#1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Cancer and Blood Institute of the Desert
According to Clinical.Site data, the most researched conditions in "Cancer and Blood Institute of the Desert" are
"Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Lung Cancer" (2 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Cancer and Blood Institute of the Desert" in a lesser frequency.
Clinical Trials Intervention Types at Cancer and Blood Institute of the Desert
Most popular intervention types in "Cancer and Blood Institute of the Desert" are "Drug" (11 trials), "Biological" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "oxaliplatin" (3 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer and Blood Institute of the Desert
The vast majority of trials in "Cancer and Blood Institute of the Desert" are
12 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Cancer and Blood Institute of the Desert
Currently, there are NaN active trials in "Cancer and Blood Institute of the Desert".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Cancer and Blood Institute of the Desert,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer and Blood Institute of the Desert, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".